- Home
- About
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Virtual Event – The Role Of Glutamate In Mood Disorders & Schizophrenia
A Virtual Live Event for PsychU members in Maryland, Washington D.C., Virginia, and eastern New York.
Glutamate is the predominant excitatory neurotransmitter in the nervous system, and glutamatergic dysregulation has been implicated in the pathophysiology of both mood disorders and schizophrenia. This presentation will examine current research in this area, provide an overview of ionotropic and metabotropic glutamate receptors, discuss the rationale for development of glutamatergic modulators in the treatment of mood disorders and schizophrenia, and review various targets for therapy.
Related Events
Register
This event registration is closed.
Topics
ClinicalStay Connected:
- Resource Library